Disease progression in idiopathic pulmonary fibrosis without pulmonary function impairment. Issue 5 (21st June 2013)
- Record Type:
- Journal Article
- Title:
- Disease progression in idiopathic pulmonary fibrosis without pulmonary function impairment. Issue 5 (21st June 2013)
- Main Title:
- Disease progression in idiopathic pulmonary fibrosis without pulmonary function impairment
- Authors:
- Kondoh, Yasuhiro
Taniguchi, Hiroyuki
Ogura, Takashi
Johkoh, Takeshi
Fujimoto, Kiminori
Sumikawa, Hiromitsu
Kataoka, Kensuke
Baba, Tomohisa
Colby, Thomas V.
Kitaichi, Masanori - Abstract:
- <abstract abstract-type="main"> <title>Abstract</title> <sec id="resp12082-sec-0001" sec-type="section"> <title>Background and objective</title> <p>Despite significant recent progress in the understanding of idiopathic pulmonary fibrosis (IPF), the early phase of the disease is still poorly understood. We studied patients with IPF without pulmonary function impairment in order to determine the clinical features, natural history and key findings for physiological progression.</p> </sec> <sec id="resp12082-sec-0002" sec-type="section"> <title>Methods</title> <p>Twenty‐five patients without pulmonary function impairment were identified from among patients with previously diagnosed IPF who underwent surgical lung biopsies between January 1997 and December 2006 at our institutions. 'Without pulmonary function impairment' was defined as both forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLco) &gt;80% predicted. Patients diagnosed with IPF through multidisciplinary discussion based on the new IPF guidelines were the subjects of this study.</p> </sec> <sec id="resp12082-sec-0003" sec-type="section"> <title>Results</title> <p>Sixteen patients had a confirmed diagnosis of IPF. Eleven patients presented with chest X‐ray abnormality found during an annual health examination. Seven patients were asymptomatic. Eleven patients showed physiological disease progression (median time; 19.9 ± 12.3 months) defined by a decline of at least 10% in FVC or at least 15% in<abstract abstract-type="main"> <title>Abstract</title> <sec id="resp12082-sec-0001" sec-type="section"> <title>Background and objective</title> <p>Despite significant recent progress in the understanding of idiopathic pulmonary fibrosis (IPF), the early phase of the disease is still poorly understood. We studied patients with IPF without pulmonary function impairment in order to determine the clinical features, natural history and key findings for physiological progression.</p> </sec> <sec id="resp12082-sec-0002" sec-type="section"> <title>Methods</title> <p>Twenty‐five patients without pulmonary function impairment were identified from among patients with previously diagnosed IPF who underwent surgical lung biopsies between January 1997 and December 2006 at our institutions. 'Without pulmonary function impairment' was defined as both forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLco) &gt;80% predicted. Patients diagnosed with IPF through multidisciplinary discussion based on the new IPF guidelines were the subjects of this study.</p> </sec> <sec id="resp12082-sec-0003" sec-type="section"> <title>Results</title> <p>Sixteen patients had a confirmed diagnosis of IPF. Eleven patients presented with chest X‐ray abnormality found during an annual health examination. Seven patients were asymptomatic. Eleven patients showed physiological disease progression (median time; 19.9 ± 12.3 months) defined by a decline of at least 10% in FVC or at least 15% in DLco. Univariate analysis revealed that both usual interstitial pneumonia pattern and extent of honeycombing on high‐resolution computed tomography (HRCT) were factors associated with disease progression (odds ratio 5.634, 95% confidence interval 1.364–23.278; odds ratio 2.371/5%, 95% confidence interval 1.042–5.395).</p> </sec> <sec id="resp12082-sec-0004" sec-type="section"> <title>Conclusions</title> <p>IPF patients without pulmonary function impairment have a progressive but slow clinical course. The existence and extent of honeycombing on HRCT are predictive of disease progression.</p> </sec> </abstract> … (more)
- Is Part Of:
- Respirology. Volume 18:Issue 5(2013)
- Journal:
- Respirology
- Issue:
- Volume 18:Issue 5(2013)
- Issue Display:
- Volume 18, Issue 5 (2013)
- Year:
- 2013
- Volume:
- 18
- Issue:
- 5
- Issue Sort Value:
- 2013-0018-0005-0000
- Page Start:
- 820
- Page End:
- 826
- Publication Date:
- 2013-06-21
- Subjects:
- Respiratory organs -- Diseases -- Periodicals
Respiratory organs -- Periodicals
612.2 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=res ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/resp.12082 ↗
- Languages:
- English
- ISSNs:
- 1323-7799
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7777.666000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4140.xml